Skip to main content
Premium Trial:

Request an Annual Quote

Advertising to Support Free Access to Journals? The Audacity!

The New York Times has an article about Reed Elsevier's latest experiment -- a program to offer oncologists free access to 100 of its journals. "Elsevier hopes to sign up 150,000 professional users within the next 12 months and to attract advertising and sponsorships, especially from pharmaceutical companies with cancer drugs to sell," according to the story. GTO knows most of you aren't card-carrying oncologists, but isn't it nice to see that a publishing giant is trying to find ways to make open access viable?

And in a related post, Pharmboy has a post at Terra Sigillata about the impressive quality of bloggers who have agreed to write content on the Elsevier site.

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.